Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Uterine Cervical Neoplasms 2Vulvar Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Ewing 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Penile Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Esophageal Neoplasms 1Anus Neoplasms 1

Interventions

Radiotherapy 3entinostat 2Trastuzumab 2Nivolumab 2Ipilimumab 2CTLA-4 Antigen 2tipifarnib 1oncogene protein E7, Human papillomavirus type 16 1fludarabine phosphate 1fludarabine 1bintrafusp alfa protein, human 1aldesleukin 1Watchful Waiting 1Therapeutics 1Specimen Handling 1Ritonavir 1Respiratory Function Tests 1Radiation 1Psychiatric Rehabilitation 1Prochlorperazine 1Positron-Emission Tomography 1Ondansetron 1Observation 1O(6)-codeine methyl ether 1Meperidine 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Loperamide 1Interleukin-2 1Interleukin-12 Subunit p35 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Vulvar Neoplasms × oncogene protein E7, Human papillomavirus type 16 × Clear all
NCT00019110 2015-04-29

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

National Cancer Institute (NCI)

Phase 1 Completed
CNSGastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Penile Neoplasms, Salivary Gland Neoplasms, Vulvar Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡